Dana J Lukin (Dana Lukin)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Venues

Inflammatory bowel diseases

Digestive diseases and sciences

Crohn's & colitis 360

Journal of clinical medicine

Weill Cornell Medical College

Icahn School of Medicine at Mount Sinai (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Weill Cornell Medical College Jul 01 2018

United States

Clinical Director of Translational Research, Jill Robers Center for IBD :: Medicine

Montefiore Hospital and Medical Center Jul 01 2013

United States

Attending :: Gastroenterology

Education History

Icahn School of Medicine at Mount Sinai Jul 01 1999

United States

PHD

Publications

Aiya Aboubakr, Dana J Lukin
Freeing Time and Reducing Costs: The Value of a Specialized Nursing Service in IBD. Inflammatory bowel diseases (2023)
Steven N Mathews, Dana J Lukin
Shifting the Inflammatory Balance in Ulcerative Colitis Through Diet: A Mediterranean Diet Pattern is Associated with Improvements in Dysbiosis and Disease Activity. Journal of Crohn's & colitis (2023)
Rochelle Wong, Lihui Qin, Yushan Pan, Prerna Mahtani, Randy Longman, Dana J Lukin, Ellen Scherl, Robert Battat
Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease. Journal of clinical medicine 12 (21) (2023)
Lasha Gogokhia, Dana J Lukin
PRO Tips: First-Rate Guidance for Second-Line Therapy After Tumor Necrosis Factor-Alpha Exposure in Patients with Crohn's Disease. Digestive diseases and sciences (2023)
Gassan Kassim, Clara Yzet, Nilendra Nair, Anketse Debebe, Alexa Rendon, Jean-Frédéric Colombel, Cindy Traboulsi, David T Rubin, Annalisa Maroli, Elisabetta Coppola, Michele M Carvello, Nadat Ben David, Francesca De Lucia, Matteo Sacchi, Silvio Danese, Antonino Spinelli, Meike M C Hirdes, Joren Ten Hove, Bas Oldenburg, Aurada Cholapranee, Maxine Riter, Dana J Lukin, Ellen Scherl, Esen Eren, Keith S Sultan, Jordan E Axelrad, David B Sachar
Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study. Inflammatory bowel diseases (2022)
Simon J Hong, Sumona Bhattacharya, Aiya Aboubakr, Devika Nadkarni, Diana Lech, Ryan C Ungaro, Manasi Agrawal, Robert P Hirten, Ruby Greywoode, Anjali Mone, Shannon Chang, David P Hudesman, Thomas Ullman, Keith Sultan, Dana J Lukin, Jean-Frederic Colombel, Jordan E Axelrad
COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study. Therapeutic advances in gastroenterology 15 (2022)
Robert Battat, Dana J Lukin, Ellen J Scherl, Suresh Pola, Anand Kumar, Lauren Okada, Lei Yang, Anjali Jain, Corey A Siegel
Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease. Inflammatory bowel diseases 27 (9) (2022)
Amneet Hans, Robert Battat, Dana J Lukin
Article Topic: Positioning Ulcerative Colitis Therapies in 2022 and Beyond. Current gastroenterology reports 24 (12) (2022)
Waseem Ahmed, Dana J Lukin
Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance. Inflammatory bowel diseases 27 (6) (2021)
Anand Kumar, Emilie S Kim, Philip Kozan, Vinita Jacob, Randy S Longman, Ellen J Scherl, Robert J Battat, Dana J Lukin
Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease. Crohn's & colitis 360 2 (4) (2020)
Anand Kumar, Tatiana Teslova, Erin Taub, Joshua D Miller, Dana J Lukin
Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications. Digestive diseases and sciences 66 (6) (2020)
Anand Kumar, Emilie S Kim, Philip Kozan, Vinita Jacob, Randy S Longman, Ellen J Scherl, Robert J Battat, Dana J Lukin
Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease. Crohn's & colitis 360 2 (4) (2020)

Dana J Lukin.css-eqlu8i{font-size:small;padding-left:4px;} (Dana Lukin)

Publication Activity (10 Years)

Top Topics

Top Venues

Dana J Lukin (Dana Lukin)